Medical and Scientific Advisor
Howard J Federoff, M.D., Ph.D., has served as a physician executive, entrepreneur, inventor, clinician, and scientist. He is the former CEO of the UCI Health System and Vice Chancellor for Health Affairs after previously serving as the Dean of the School of Medicine. Previously, he was EVP Health Sciences/Executive Dean at Georgetown University. A clinical and research leader and an investigator in gene therapy and neurological disorders, his research led to a new gene therapy trial in Parkinson’s disease, and in predicting the onset of Alzheimer’s disease. He has published many peer-reviewed and invited articles, holds a number of patents and serves on the editorial boards for several journals. He chaired the NIH Recombinant DNA Advisory Committee and the Gene Therapy Resource Program for NHLBI and chaired the Association of Academic Health Centers Board. He is an elected Fellow of the American Association for the Advancement of Science and the National Academy of Inventors.
Dr. Federoff co-founded several biotechnology companies including MedGenesis Therapeutix, a platform company using convection-enhanced technology to deliver biologics to the brain of patients with Parkinson’s disease.
Dr. Federoff received his MS, Ph.D., and MD from the Albert Einstein College of Medicine, and completed his internship, residency, and fellowships at the Massachusetts General Hospital, Harvard Medical School.